“Prevention is better than care” as they say, this age-old phrase has never been more relevant. With the aging population, rising incidence of chronic diseases, and skyrocketing healthcare costs, the public health focus is shifting toward preventive medicine. Several governments across the world are prioritizing public health and investing in preventive healthcare practices.
Before a deep dive into technical terms, let’s first understand what preventive healthcare is.
What is preventive healthcare?
Preventive healthcare refers to the routine practice of healthcare checkups, and taking necessary measures to prevent the occurrence of any kind of disease. Among the adult population, preventive healthcare refers to early screening for conditions such as diabetes, cardiovascular diseases, cancers, etc, and among children, vaccination, newborn screening, genetic testing for inherited diseases, etc are the major preventive healthcare steps.
Why is preventive healthcare important?
The practice of preventive healthcare is essential to reduce the risk of chronic disease occurrence and reduce the overall global burden of diseases. The practice of preventive healthcare reduces the overall economic burden by reducing treatment costs, resource allocation, and both direct and indirect medical costs.
Did you know? Every US$1 spent on childhood vaccination saves US$3 in direct medical costs and US$10 in societal costs.
What are the various segments in preventive healthcare?
Preventive healthcare is majorly segmented into three types.
- Primary prevention
Refers to measures taken before the occurrence/incidence of a disease. The common measures include vaccination, risk factor detections, genetic screenings, general public awareness, etc.
- Secondary prevention
Refers to measures taken in populations who are at a risk of disease occurrence. This includes measures like early-stage diagnosis, regular health screening, early interventions, etc.
- Tertiary prevention
Refers to measures taken in the patient population to further slow the disease progression and improve the overall patient’s quality of life. This includes measures like rehabilitation programs, condition management, etc.
What is the current market scenario for preventive healthcare?
As per DataM analysis, the market for preventive healthcare stood at US$ 388 billion in 2024 and is expected to reach a whopping US$ 1,161 billion by 2032, with a recorded CAGR of 14.1%.

What are the drivers for preventive healthcare market growth?
Several factors are driving the preventive healthcare market and the major ones include the rising government initiatives and investments, rising awareness and practices of preventive healthcare, and technological innovations for early disease screening.
Key investments driving the preventive healthcare market landscape
The private and government investments to promote the practice of preventive healthcare are a key driver for the market growth. These investments are growing in various preventive healthcare sectors such as vaccinations, public health monitoring, disease screening programs, early-stage diagnostics, and awareness campaigns.
For instance, Gavi has stated that between the period of 2026-2030, Gavi and the vaccine partners plan to strengthen the global vaccination programs with huge investments. During the period, the vaccine alliance plans to save 8 to 9 million lives and immunize 500 million children through a financial contribution of US$ 4 billion through domestic co-financing and self-funded vaccine programs.
In addition to global public health agencies, each nation is investing heavily in preventive healthcare.
For instance, for the financial year 2024-25, India’s Ministry of Health and Family Welfare (MoHFW) has allocated a budget of ~US$10.2 billion for the Department of Health & Family Welfare (DoHFW). Moreover, ~US$8.1 billion in grants for health through the local Governments were provided by the 15th Finance Commission. The health budget has seen a rise of 85% from the fiscal year 2017-18 and is heavily focused on preventive healthcare practices. In addition, till 10th December 2024, 1,75,418 Ayushman Arogya Mandirs (AAMs) have been established and operationalized whose function is to perform primary healthcare services including preventive medicine.
Moreover, in 2024, Agence de l’innovation en santé, AIS of France announced an investment of ~ US$180 million to support the development of novel devices and other research activities related to preventive healthcare. With a focus on eight fields such as children’s health, mental health, infertility, chronic diseases, infectious disease, rare diseases, and addiction, AIS has allocated the budget for three development areas such as large-scale projects, a research program on environmental factors and industrial projects that develop preventive technologies.
These are just a few examples in the ocean of preventive healthcare investments. Private investments are coming from every corner of the world, with companies and venture capitalists recognizing the immense potential of prioritizing preventive healthcare over curative medicine.
Discover more from Industry News | Latest News, Trends & Market Insights.
Subscribe to get the latest posts sent to your email.
